Tag Archives: RCEP

India & RCEP: The end of low cost medications?

India & RCEP: The end of low cost medications?
Danesh Kermabon-Haq

Danesh Kermabon-Haq

Policy Researcher at Politheor
Danesh Kermabon-Haq holds a BA degree in Politics and International Relations from the University of Sussex, UK and an MSc in International Public Policy from University College London (UCL), UK.His MSc thesis focused on ‘trade liberalisation and income inequality in South Asia’. His BA thesis focused on ‘worker cooperatives as a viable alternative to corporate capitalist enterprises today’. His areas of interest include trade liberalisation, EU policies and socio-economic issues in developing countries.
Danesh Kermabon-Haq

Latest posts by Danesh Kermabon-Haq (see all)

Share

India’s pharmaceutical industry will be limited by the proposed TRIPS Plus clauses within the Regional Comprehensive Economic Partnership (RCEP) between ASEAN and their trading partners. These would make large production more complex causing medicine prices to go up and thus rendering them less accessible, especially for people living in developing countries. The RCEP is a […]

Read More 0 Comments